White matter hyperintensities, cognitive impairment and dementia: an update
- PMID: 25686760
- DOI: 10.1038/nrneurol.2015.10
White matter hyperintensities, cognitive impairment and dementia: an update
Abstract
White matter hyperintensities (WMHs) in the brain are the consequence of cerebral small vessel disease, and can easily be detected on MRI. Over the past three decades, research has shown that the presence and extent of white matter hyperintense signals on MRI are important for clinical outcome, in terms of cognitive and functional impairment. Large, longitudinal population-based and hospital-based studies have confirmed a dose-dependent relationship between WMHs and clinical outcome, and have demonstrated a causal link between large confluent WMHs and dementia and disability. Adequate differential diagnostic assessment and management is of the utmost importance in any patient, but most notably those with incipient cognitive impairment. Novel imaging techniques such as diffusion tensor imaging might reveal subtle damage before it is visible on standard MRI. Even in Alzheimer disease, which is thought to be primarily caused by amyloid, vascular pathology, such as small vessel disease, may be of greater importance than amyloid itself in terms of influencing the disease course, especially in older individuals. Modification of risk factors for small vessel disease could be an important therapeutic goal, although evidence for effective interventions is still lacking. Here, we provide a timely Review on WMHs, including their relationship with cognitive decline and dementia.
Similar articles
-
The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease.Eur J Neurol. 2012 Aug;19(8):1100-7. doi: 10.1111/j.1468-1331.2012.03682.x. Epub 2012 Feb 23. Eur J Neurol. 2012. PMID: 22360775
-
Factors associated with cerebral white matter hyperintensities in haemodialysis patients.Nephrology (Carlton). 2012 Aug;17(6):561-8. doi: 10.1111/j.1440-1797.2012.01596.x. Nephrology (Carlton). 2012. PMID: 22429518
-
Review of cerebral microangiopathy and Alzheimer's disease: relation between white matter hyperintensities and microbleeds.Dement Geriatr Cogn Disord. 2011;32(6):367-78. doi: 10.1159/000335568. Epub 2012 Feb 1. Dement Geriatr Cogn Disord. 2011. PMID: 22301385 Review.
-
Severity of White Matter Hyperintensities and Length of Hospital Stay in Patients with Cognitive Impairment: A CREDOS (Clinical Research Center for Dementia of South Korea) Study.J Alzheimers Dis. 2015;46(3):719-26. doi: 10.3233/JAD-142823. J Alzheimers Dis. 2015. PMID: 25854927
-
White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities.Alzheimers Dement (N Y). 2019 Apr 9;5:107-117. doi: 10.1016/j.trci.2019.02.001. eCollection 2019. Alzheimers Dement (N Y). 2019. PMID: 31011621 Free PMC article. Review.
Cited by
-
Effect of cerebral small vessel disease on cognitive impairment in Parkinson's disease.Acta Neurol Belg. 2023 Apr;123(2):487-495. doi: 10.1007/s13760-022-02078-w. Epub 2022 Sep 12. Acta Neurol Belg. 2023. PMID: 36097211
-
The Different Associations of White Matter Hyperintensities With Severity of Dementia and Cognitive Impairment According to the Distance From the Lateral Ventricular Surface in Patients With Alzheimer's Disease.Psychiatry Investig. 2024 Aug;21(8):850-859. doi: 10.30773/pi.2024.0082. Epub 2024 Aug 8. Psychiatry Investig. 2024. PMID: 39111744 Free PMC article.
-
Associations of Amyloid Burden, White Matter Hyperintensities, and Hippocampal Volume With Cognitive Trajectories in the 90+ Study.Neurology. 2024 Aug 13;103(3):e209665. doi: 10.1212/WNL.0000000000209665. Epub 2024 Jul 15. Neurology. 2024. PMID: 39008782
-
Genetic and Environmental Effects on the Development of White Matter Hyperintensities in a Middle Age Twin Population.Medicina (Kaunas). 2022 Oct 10;58(10):1425. doi: 10.3390/medicina58101425. Medicina (Kaunas). 2022. PMID: 36295585 Free PMC article.
-
Investigating the association between a history of depression and biomarkers of Alzheimer's disease, cerebrovascular disease, and neurodegeneration in patients with dementia.Geroscience. 2024 Feb;46(1):783-793. doi: 10.1007/s11357-023-01030-x. Epub 2023 Dec 14. Geroscience. 2024. PMID: 38097855 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous